Clinical Trial Update: Antithymocyte Globulin and Azathioprine Versus Basiliximab and Mycophenolate Mofetil in Living Donor Kidney Transplantation [Phase 4]

View source ↗

Summary

Phase 4 clinical trial comparing antithymocyte globulin with azathioprine to basiliximab with mycophenolate mofetil in living donor kidney transplantation for k…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Kidney Transplant
• Kidney Transplant Rejection

Drugs mentioned

• Antithymocyte Globulin (anti-thymocyte globulin)
• Azathioprine (azathioprine)
• Basiliximab (basiliximab)
• MYCOPHENOLATE MOFETIL (MYCOPHENOLATE MOFETIL)

Snippet

Sponsor: University of Khartoum | Conditions: Kidney Transplant Rejection | Phase 4 | Status: UNKNOWN